Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus.
about
Evidence of henipavirus infection in West African fruit batsEphrin-B2 ligand is a functional receptor for Hendra virus and Nipah virusModes of paramyxovirus fusion: a Henipavirus perspectiveInhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein.Henipavirus mediated membrane fusion, virus entry and targeted therapeuticsHendra virusHost cell recognition by the henipaviruses: Crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3Crystal Structure and Carbohydrate Analysis of Nipah Virus Attachment Glycoprotein: a Template for Antiviral and Vaccine DesignDimeric Architecture of the Hendra Virus Attachment Glycoprotein: Evidence for a Conserved Mode of AssemblyStructure of the measles virus hemagglutinin bound to its cellular receptor SLAMHendra virus and Nipah virus animal vaccines.Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.Hendra and Nipah viruses: different and dangerous.Preparation of recombinant viral glycoproteins for novel and therapeutic antibody discovery.Antiviral activity of gliotoxin, gentian violet and brilliant green against Nipah and Hendra virus in vitroDevelopment of an acute and highly pathogenic nonhuman primate model of Nipah virus infection.Emerging tropical diseases in Australia. Part 5. Hendra virusVaccine potential of Nipah virus-like particlesStructural and mechanistic studies of measles virus illuminate paramyxovirus entry.Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: Implications for mechanisms of immune evasion and design of vaccine immunogensProbing the functions of the paramyxovirus glycoproteins F and HN with a panel of synthetic antibodies.A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge.Rapid detection of hendra virus using magnetic particles and quantum dots.A functional henipavirus envelope glycoprotein pseudotyped lentivirus assay system.Induction of neutralizing antibodies to Hendra and Nipah glycoproteins using a Venezuelan equine encephalitis virus in vivo expression system.Rhabdovirus-based vaccine platforms against henipavirusesHenipavirus outbreaks to antivirals: the current status of potential therapeutics.Feline model of acute nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine.Viral antibody dynamics in a chiropteran host.A treatment for and vaccine against the deadly Hendra and Nipah virusesTiming is everything: Fine-tuned molecular machines orchestrate paramyxovirus entry.Hendra and nipah infection: pathology, models and potential therapies.Emerging paramyxoviruses: molecular mechanisms and antiviral strategiesImmunization strategies against henipavirusesSite occupancy and glycan compositional analysis of two soluble recombinant forms of the attachment glycoprotein of Hendra virus.N-linked glycosylation attenuates H3N2 influenza viruses.Cysteines in the stalk of the nipah virus G glycoprotein are located in a distinct subdomain critical for fusion activation.New insights into the Hendra virus attachment and entry process from structures of the virus G glycoprotein and its complex with Ephrin-B2Developments towards effective treatments for Nipah and Hendra virus infection.Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccines.
P2860
Q21562616-8C1D8946-E007-4145-A00F-0BC5EEE980F0Q24532042-F8173323-1B1E-4D56-A9F7-5C949C208BABQ24604089-E18B0EA4-B353-4C1D-992C-121E561F6ADAQ24814238-704015C0-9DBE-42B0-8D6A-5AAB04CBE802Q27002511-6A4A7946-E844-49C9-96B3-64CCFEEE37B4Q27006568-38886114-2A2E-4D23-822E-51CB3B7FC48AQ27651214-8FB000FA-4BE6-41E0-A402-B3B315EB7D73Q27652284-A402276E-E768-432D-9FD5-814C41D02988Q27660451-AA8F984C-553A-4B23-AEB2-3B31E1C70827Q27666483-1609C184-4474-458B-B476-353D09E44324Q30387821-8EB973AE-CA65-4867-9D26-7F69C0844D1BQ30805028-CAA3E5B0-0CE3-4547-8932-23EAF6DAFEADQ31026413-B83E022D-28F1-4AE8-8AB6-399296E963A0Q33413784-BE17CC6D-4EFA-4696-A23B-A00735547465Q33514948-F52BF137-4A61-42C7-B43D-4763A6FCA741Q33587327-49833921-1E62-404A-91F4-1F7DD0C39E8CQ33812171-B9B4CD6F-88C1-4B76-8F06-44A9682E3037Q33873756-6961A0FF-DC3B-4228-AB2D-F035C70D2D77Q33926896-A1935BAC-AA6C-4A18-81BB-9BCCC0EE2370Q34121215-4065E1C8-C1F7-41E7-8447-3C750B1F0BC2Q34261586-82711436-E501-48B4-9E49-46C0069E4FC5Q34292954-F0EE9958-63C2-4E50-B9B2-74A235AD6143Q34313919-40D2073F-9A33-45C2-9A53-B69D40E78C0BQ34365035-C212589F-EA38-41ED-8260-4D243EF6743BQ34545923-FDDF1B77-2738-4DEA-AE47-564D8075A696Q34992537-92AD1854-8C0C-44D2-9727-6FDB023142EFQ35141580-D17A5DC1-0C8A-47B8-B25E-ACD976BD7B11Q35185973-BE6921A9-0008-459A-B082-C4CE5DB7F9F2Q35550671-8AC33DC1-DE36-401D-89DC-2179D212DA78Q35565878-016BF510-3E31-44B4-8B54-B138AB94D96FQ35582400-6D692307-EE85-4A85-A3E7-63203B81AAD7Q35658146-E02ECD0D-6123-4D44-B056-EDD1122DDDEFQ35658152-1091DF4D-71F6-4585-9343-8E05DA3A49D5Q35735589-FECABFC5-FDBA-407F-B0AC-0BB701C69EFFQ35779475-EF068E4B-80D9-4B07-9DED-CE9BD8F1D6A9Q35947697-563AC4F3-115B-4A17-85C4-E1B626B9156EQ36086698-08E98269-5E0B-4FF4-B79E-EC1CBF64511DQ36373573-477B2913-3A3C-4562-920E-F6B58054FC74Q36379335-B50A350B-E6FC-4903-9028-376440CD6B9AQ36779713-DD5FB7F6-FFFA-4012-8937-AF04D97BF17F
P2860
Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Receptor binding, fusion inhib ...... glycoprotein of Hendra virus.
@en
type
label
Receptor binding, fusion inhib ...... glycoprotein of Hendra virus.
@en
altLabel
Receptor binding, fusion inhib ...... G glycoprotein of Hendra virus
@en
prefLabel
Receptor binding, fusion inhib ...... glycoprotein of Hendra virus.
@en
P2093
P2860
P50
P921
P1433
P1476
Receptor binding, fusion inhib ...... glycoprotein of Hendra virus.
@en
P2093
Anil Choudhary
Antony S Dimitrov
Bryan T Eaton
Christopher C Broder
Gary Crameri
Jared R Patch
Yan-Ru Feng
P2860
P304
P356
10.1128/JVI.79.11.6690-6702.2005
P407
P577
2005-06-01T00:00:00Z